Immunophenotypic Characterization of Human Glioblastoma Stem Cells: Correlation With Clinical Outcome

βIII-Tubulin Overexpression Is an Independent Predictor of Prostate Cancer Progression Tightly Linked to ERG Fusion Status and PTEN Deletion

(2014) Maria C. Tsourlakis et al.   AMERICAN JOURNAL OF PATHOLOGY

Statins Do Not Influence Long-Term Rituximab Clinical Efficiency in Rheumatoid Arthritis Patients

(2014) Diana Mazilu et al.   Biomed Research International

Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes

(2013) Daniel Stieber et al.   ACTA NEUROPATHOLOGICA

Cell surface Nestin is a biomarker for glioma stem cells

(2013) Xiong Jin et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Characteristics of glioma stem cells

(2013) Oltea Sampetrean et al.   Brain Tumor Pathology

Clinicopathological significance of expression of nestin, a neural stem/progenitor cell marker, in human glioma tissue

(2013) Takehiro Tomita et al.   Brain Tumor Pathology

Astrocytes Enhance the Invasion Potential of Glioblastoma Stem-Like Cells

(2013) Barbara H. Rath et al.   PLoS One

Impact of CD133 positive stem cell proportion on survival in patients with glioblastoma multiforme

(2013) Marju Kase et al.   Radiology and Oncology

SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells

(2013) M Herreros-Villanueva et al.   Oncogenesis

Nestin expression in brain tumors: its utility for pathological diagnosis and correlation with the prognosis of high-grade gliomas

(2012) Hideo Arai et al.   Brain Tumor Pathology

Glioblastoma cancer stem cells – From concept to clinical application

(2012) Barbara E. Stopschinski et al.   CANCER LETTERS

Elevating SOX2 Levels Deleteriously Affects the Growth of Medulloblastoma and Glioblastoma Cells

(2012) Jesse L. Cox et al.   PLoS One

Association of Stem Cell-Related Markers and Survival in Astrocytic Gliomas

(2011) Feng Wan et al.   BIOMARKERS

Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression

(2011) Federica Gambelli et al.   CELL BIOLOGY INTERNATIONAL

Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas

(2011) U Basu-Roy et al.   ONCOGENE

Sox2 expression in breast tumours and activation in breast cancer stem cells

(2011) O Leis et al.   ONCOGENE

GFAP in health and disease

(2011) J. Middeldorp et al.   PROGRESS IN NEUROBIOLOGY

Glioblastoma Stem-Like Cells—Biology and Therapeutic Implications

(2011) Demirkan B. Gürsel et al.   Cancers

Recent Advances in Therapy for Glioblastoma

(2010) Jennifer Clarke et al.   ARCHIVES OF NEUROLOGY

CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors

(2010) Cristina Patru et al.   BMC CANCER

Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis

(2010) Roberto Pallini et al.   CANCER

Glioma Cell Populations Grouped by Different Cell Type Markers Drive Brain Tumor Growth

(2010) Lars Prestegarden et al.   CANCER RESEARCH

Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients

(2010) T. Di Tomaso et al.   CLINICAL CANCER RESEARCH

Sox2 Expression in Brain Tumors: A Reflection of the Neuroglial Differentiation Pathway

(2009) Ji Hoon Phi et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Arrested neural and advanced mesenchymal differentiation of glioblastoma cells-comparative study with neural progenitors

(2009) Piotr Rieske et al.   BMC CANCER

Cancer stem cells: Cell culture, markers, and targets for new therapies

(2009) Candace A. Gilbert et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. class III β-tubulin

(2009) Christos D. Katsetos et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Class III β-Tubulin Is Constitutively Coexpressed With Glial Fibrillary Acidic Protein and Nestin in Midgestational Human Fetal Astrocytes: Implications for Phenotypic Identity

(2009) Eduarda Dráberová et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme

(2008) R. Pallini et al.   CLINICAL CANCER RESEARCH

Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients

(2008) F. Zeppernick et al.   CLINICAL CANCER RESEARCH

Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients

(2008) Mingyu Zhang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas

(2008) Kyeung Min Joo et al.   LABORATORY INVESTIGATION

Glioma Stem Cells: A Midterm Exam

(2008) Charles D. Stiles et al.   NEURON

New strategy for the analysis of phenotypic marker antigens in brain tumor–derived neurospheres in mice and humans

(2008) Anne-Marie Bleau et al.   Neurosurgical Focus

Malignant Gliomas in Adults

(2008) Patrick Y. Wen et al.   NEW ENGLAND JOURNAL OF MEDICINE

SOX2Silencing in Glioblastoma Tumor-Initiating Cells Causes Stop of Proliferation and Loss of Tumorigenicity

(2008) Rosaria Maria Rita Gangemi et al.   STEM CELLS

CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells

(2007) Jian Wang et al.   INTERNATIONAL JOURNAL OF CANCER